You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Rev. ed. of: Clinical gynecologic oncology / Philip J. DiSaia, William T. Creaseman. 7th ed. 2007.
Today, multidisciplinary approaches to treatment are at the heart of cancer care. They offer improved clinical outcomes, new possibilities in patient quality of life, and enable the development of true innovation in individualized treatment. To accurately reflect this modern day approach to cancer care, the content of the 6th edition of Principles and Practice of Gynecologic Oncology was written entirely by surgeons, medical oncologists, radiation oncologists, and pathologists. New to the editorial team, Dr. Andrew Berchuck has made significant contributions to the understanding of the molecular pathogenesis of ovarian and endometrial cancer in the book’s content. Every chapter of this book has been either completely rewritten or extensively updated to ensure that everyone involved in treating women with gynecologic cancer will have the most comprehensive and up-to-date information on the subject.
Providing comprehensive coverage of the biology of gynecologic cancer, the therapeutic modalities available, and the diagnosis and treatment of site-specific malignancies, this edition has 30 percent new contributing authors and new material. A companion Web site offers a fully searchable text.
Gynecological Tumor Board is a comprehensive reference on clinical management of reproductive system cancers in women. Twenty nationally recognized leaders in the field of Gynecologic Oncology present cases--from diagnosis through medical/surgical treatment through QOL and long-term care--that reflect the clinical scenarios often found in a Gynecologic Oncology clinic, and present the best current guidelines for treating these conditions. Special Editors' Comments provide expert analysis and counterpoint to the cases.
In a world of seemingly never-ending technological advances, questions of ethics take on even more significance than in the past. Conflicts of interest abound and pressure mounts at every turn for more profits, higher incomes, power and instant gratification leads to the temptation to ignore questions of ethics. This book presents new and interesting research on ethical issues in the modern day.
Gynecologic oncology takes a fresh look at a critical aspect of cancer treatment planning. An international team of authors reviews the traditional prognostic and predictive factors such as tumor grade, histologic subtype, and grade and then goes a step further to review the growing number of molecular discoveries that have increasing clinical significance. The book is organized into comprehensive sections on ovarian, endometrial and cervical cancer and includes up to date reviews, newly discovered molecular pathways, genetic markers, molecular imaging techniques, and their relevance to clinical medicine. Prognostic and Predictive Factors in Gynecologic Oncology is illustrated with over 100 figures and is essential reading for oncologists, translational and basic scientists, as well as fellows, residents and students with a special interest in gynecologic oncology.
Dynamic contrast-enhanced MRI is now established as the methodology of choice for the assessment of tumor microcirculation in vivo. The method assists clinical practitioners in the management of patients with solid tumors and is finding prominence in the assessment of tumor treatments, including anti-angiogenics, chemotherapy, and radiotherapy. Here, leading authorities discuss the principles of the methods, their practical implementation, and their application to specific tumor types. The text is an invaluable single-volume reference that covers all the latest developments in contrast-enhanced oncological MRI.
Advances in the Use of Synthons in Organic Chemistry: A Research Annual, Volume 1 provides information pertinent to a useful reagent that can perform a certain chemical operation that is otherwise impossible or difficult to carry out. This book presents the developments on established synthons. Organized into four chapters, this volume begins with an overview of the significant role of the formyl group in synthetic methodologies, which has stimulated the search for other reagents. This text then describes trimethysilyldiazomethane as a stable and safe substitute for hazardous diazomethane. Other chapters consider the usefulness of trimethysilyldiazomethane in organic syntheses. This book discusses as well that malonic amides, silylenol ethers, malonic esters, and tetra-donor-substituted allenes serve as synthetic equivalents for the dianions of malonic esters, ketones, and malonic amides. The final chapter deals with the synthesis of biologically-active compounds, which has been one of the major challenges for organic chemists. This book is a valuable resource for practicing synthetic chemists.
Conn's Current Therapy 2010 provides concise and easy-to-use guidance on the latest advances in therapeutics for common complaints and diagnoses. Edward T. Bope, MD; Robert E. Rakel, MD; and Rick D. Kellerman offer their expertise and the knowledge of hundreds of skilled international leaders on the full range of evidence-based management options. Tap into recent developments and thorough updates on myelodysplastic syndromes, psychocutaneous medicine, recently-approved and soon-to-be-approved drugs, and much more to stay on top of current treatment practices. With the full text online at expertconsult.com, you'll have the information you need right at your fingertips for easy access! Provide...
As the first edition of this book was going through the publication process, a revolution was taking place in the technologies available for the study of enzymes. The techniques of molecular biology, especially in genetic engineering of organisms and in site specific mutagenesis of genes, were established and were being brought into use to solve many problems in in enzymology. Added to these fundamental and applied science, not least advances the possibility of generating catalysts from antibodies has become a topic of major interest. These major innovations have changed the emphasis of much bioorganic research; whereas in the past, the protein was often the 'sleeping partner' ina study, its...